Cargando…

Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits

Cognitive impairment is a common non-motor feature of Parkinson's disease (PD). Understanding the neural mechanisms of this deficit is crucial for the development of efficient methods for treatment monitoring and augmentation of cognitive functions in PD patients. The current study aimed to inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lebedev, Alexander V., Westman, Eric, Simmons, Andrew, Lebedeva, Aleksandra, Siepel, Françoise J., Pereira, Joana B., Aarsland, Dag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982053/ https://www.ncbi.nlm.nih.gov/pubmed/24765065 http://dx.doi.org/10.3389/fnsys.2014.00045

Ejemplares similares

MRI-Based Classification Models in Prediction of Mild Cognitive Impairment and Dementia in Late-Life Depression
por: Lebedeva, Aleksandra K., et al.
Publicado: (2017)

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
por: Buddhala, Chandana, et al.
Publicado: (2015)

Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease
por: Kaasinen, Valtteri
Publicado: (2015)

Comparison of resting tremor at the upper limb joints between patients with Parkinson’s disease and scans without evidence of dopaminergic deficit
por: Kwon, Do-Young, et al.
Publicado: (2023)

Theory of mind deficits in Parkinson’s disease are not modulated by dopaminergic medication
por: Usnich, Tatiana, et al.
Publicado: (2023)

Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression
por: Pereira, Joana B., et al.
Publicado: (2019)

Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients
por: Rektorova, Irena, et al.
Publicado: (2014)

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson’s disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
por: Fereshtehnejad, Seyed-Mohammad, et al.
Publicado: (2013)

Dopaminergic pathways and resting-state functional connectivity in Parkinson’s disease with freezing of gait
por: Steidel, Kenan, et al.
Publicado: (2021)

Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways
por: Green, Holly, et al.
Publicado: (2019)

Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression
por: Concha‐Marambio, Luis, et al.
Publicado: (2021)

((123)I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study
por: Siepel, Françoise J, et al.
Publicado: (2013)

Heptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice
por: Hong, Seokheon, et al.
Publicado: (2014)

Exercise Ameliorates Motor Deficits and Improves Dopaminergic Functions in the Rat Hemi-Parkinson’s Model
por: Chen, Yuan-Hao, et al.
Publicado: (2018)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Nonmotor Symptoms of Parkinson's Disease
por: Rektorova, Irena, et al.
Publicado: (2011)

Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease?
por: Stockner, Heike, et al.
Publicado: (2012)

Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit
por: Yu, Zhenwei, et al.
Publicado: (2021)

Female Rats Are Resistant to Cognitive, Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson’s Disease
por: Lima, Alvaro C., et al.
Publicado: (2021)

Impaired synaptic function is linked to cognition in Parkinson's disease
por: Selnes, Per, et al.
Publicado: (2017)

Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases
por: Hessen, Erik, et al.
Publicado: (2016)

Cognitive Interventions in Parkinson’s Disease: Where We Want to Go within 20 Years
por: Kalbe, Elke, et al.
Publicado: (2018)

Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
por: Oikonomou, Panteleimon, et al.
Publicado: (2021)

Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study
por: Kazmi, Hiba, et al.
Publicado: (2021)

Dopaminergic and Cholinergic Modulation of Large Scale Networks in silico Using Snudda
por: Frost Nylen, Johanna, et al.
Publicado: (2021)

Drug and Disease Effects in Parkinson's Psychosis: Revisiting the Role of Dopamine
por: Dave, Sonali, et al.
Publicado: (2019)

A Multi-Scale Computational Model of Excitotoxic Loss of Dopaminergic Cells in Parkinson's Disease
por: Muddapu, Vignayanandam Ravindernath, et al.
Publicado: (2020)

Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?
por: Furgiuele, Alessia, et al.
Publicado: (2023)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Resting-state EEG measures cognitive impairment in Parkinson’s disease
por: Anjum, Md Fahim, et al.
Publicado: (2023)

The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia
por: Stubendorff, Kajsa, et al.
Publicado: (2012)

Mediating Effect of Mutuality on Health-Related Quality of Life in Patients with Parkinson's Disease
por: Karlstedt, Michaela, et al.
Publicado: (2018)

Determinants of Dyadic Relationship and Its Psychosocial Impact in Patients with Parkinson's Disease and Their Spouses
por: Karlstedt, Michaela, et al.
Publicado: (2017)

A dopaminergic deficit hypothesis of schizophrenia: the path to discovery
por: Carlsson, Arvid, et al.
Publicado: (2006)

Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson’s disease
por: Drouin-Ouellet, Janelle, et al.
Publicado: (2022)

Dopaminergic medication impairs feedback-based stimulus-response learning but not response selection in Parkinson's disease
por: Vo, Andrew, et al.
Publicado: (2014)

Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson’s disease: Analysis of the PPMI data
por: Lee, Jeong Won, et al.
Publicado: (2021)

Nicotine-Mediated Recruitment of GABAergic Neurons to a Dopaminergic Phenotype Attenuates Motor Deficits in an Alpha-Synuclein Parkinson’s Model
por: Lai, Jessica IChi, et al.
Publicado: (2023)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
por: Redenšek, Sara, et al.
Publicado: (2019)

Visuo-Motor Coordination Deficits and Motor Impairments in Parkinson's Disease
por: Inzelberg, Rivka, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_h0edl4apu3bnvc0ohcajigbnan